PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.81%
Revenue growth above 1.5x ADI's 1.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
9.81%
Gross profit growth 1.25-1.5x ADI's 7.04%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
15.53%
EBIT growth above 1.5x ADI's 6.32%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
15.39%
Operating income growth above 1.5x ADI's 6.32%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
15.19%
Net income growth above 1.5x ADI's 3.69%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
15.71%
EPS growth above 1.5x ADI's 3.77%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
14.49%
Diluted EPS growth above 1.5x ADI's 5.77%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.32%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.20%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.06%
Dividend growth under 50% of ADI's 5.03%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
95.43%
OCF growth above 1.5x ADI's 45.74%. David Dodd would confirm a clear edge in underlying cash generation.
115.37%
FCF growth above 1.5x ADI's 49.91%. David Dodd would verify if the firm’s strategic investments yield superior returns.
37.03%
10Y revenue/share CAGR at 75-90% of ADI's 42.66%. Bill Ackman would press for new markets or product lines to narrow the gap.
9.05%
Positive 5Y CAGR while ADI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
18.09%
3Y revenue/share CAGR similar to ADI's 17.61%. Walter Schloss would assume both companies experience comparable short-term cycles.
158.94%
10Y OCF/share CAGR above 1.5x ADI's 84.11%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
95.19%
5Y OCF/share CAGR above 1.5x ADI's 58.16%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
74.36%
3Y OCF/share CAGR above 1.5x ADI's 26.42%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-46.89%
Negative 10Y net income/share CAGR while ADI is at 37.97%. Joel Greenblatt sees a major red flag in long-term profit erosion.
40.42%
Positive 5Y CAGR while ADI is negative. John Neff might view this as a strong mid-term relative advantage.
36.42%
3Y net income/share CAGR above 1.5x ADI's 3.26%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
20.58%
Below 50% of ADI's 57.80%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
5.27%
Below 50% of ADI's 32.15%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-1.05%
Negative 3Y equity/share growth while ADI is at 8.79%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
1158.01%
10Y dividend/share CAGR above 1.5x ADI's 246.79%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
193.41%
5Y dividend/share CAGR above 1.5x ADI's 91.21%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
35.90%
3Y dividend/share CAGR above 1.5x ADI's 23.89%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
6.23%
AR growth well above ADI's 6.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.93%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.04%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.17%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-12.29%
We’re deleveraging while ADI stands at 0.02%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
5.90%
R&D growth drastically higher vs. ADI's 1.78%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.95%
SG&A growth well above ADI's 4.40%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.